These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8580007)

  • 1. When should essential hypertension in childhood be treated and how?
    Ingelfinger JR
    Pediatr Nephrol; 1995 Oct; 9(5):552. PubMed ID: 8580007
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug effects on blood pressure rhythms in essential hypertension.
    Rosenthal T
    Ann N Y Acad Sci; 1996 Aug; 783():263-9. PubMed ID: 8853648
    [No Abstract]   [Full Text] [Related]  

  • 3. Influencing the natural history of hypertension: it is the blood pressure achieved more than the drug.
    Fagard RH
    J Hypertens; 2008 Aug; 26(8):1533-5. PubMed ID: 18622225
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood pressure reduction in hypertension--what is the optimal target value?].
    Januszewicz W; Januszewicz A
    Kardiol Pol; 2004 Nov; 61(11):505-10. PubMed ID: 15883611
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive treatment: is blood pressure-lowering the only goal?
    Zanchetti A
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S48-50. PubMed ID: 1726007
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood pressure variability: an additional target for antihypertensive treatment?
    Schillaci G; Pucci G; Parati G
    Hypertension; 2011 Aug; 58(2):133-5. PubMed ID: 21747045
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing patients with high blood pressure before the introduction of antihypertensive drugs.
    Roberts WC
    Am J Cardiol; 2005 Nov; 96(10):1465-6. PubMed ID: 16275202
    [No Abstract]   [Full Text] [Related]  

  • 8. 24-hour powerful blood pressure lowering - essential for target organ protection.
    Cardiovasc J Afr; 2010; 21(1):61-2. PubMed ID: 20224852
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension.
    White WB; Lacourciere Y
    J Hypertens; 2004 Oct; 22(10):2035-6; author reply 2036-8. PubMed ID: 15361777
    [No Abstract]   [Full Text] [Related]  

  • 10. Questionable link between normo- to microalbuminuria and home-measured blood pressure variability in hypertension.
    Tamura K; Shibuya K; Takeshita Y; Koide Y; Tokita Y; Umemura S
    Hypertens Res; 2012 Aug; 35(8):802-4. PubMed ID: 22648061
    [No Abstract]   [Full Text] [Related]  

  • 11. New Clinical Practice Guideline for the Management of High Blood Pressure in Children and Adolescents.
    Flynn JT; Falkner BE
    Hypertension; 2017 Oct; 70(4):683-686. PubMed ID: 28827475
    [No Abstract]   [Full Text] [Related]  

  • 12. SPRINT, or False Start, Toward a Lower Universal Treated Blood Pressure Target in Hypertension.
    Esler M
    Hypertension; 2016 Feb; 67(2):266-7. PubMed ID: 26553232
    [No Abstract]   [Full Text] [Related]  

  • 13. How far should blood pressure be lowered?
    Birkenhäger WH; de Leeuw PW
    Drugs; 1988 Jul; 36(1):7-10. PubMed ID: 3063496
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of hypertension in the elderly].
    Serro-Azul JB; Wajngarten M; Serro-Azul LG
    Arq Bras Cardiol; 1990 Feb; 54(2):141-5. PubMed ID: 2260940
    [No Abstract]   [Full Text] [Related]  

  • 15. Bosentan in essential hypertension.
    Haynes WG; Ferro CJ; Webb DJ
    N Engl J Med; 1998 Jul; 339(5):346; author reply 347. PubMed ID: 9696644
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating the true prevalence of resistant hypertension.
    Anyfanti P; Gavriilaki E; Douma S
    Hypertension; 2011 Oct; 58(4):e23; author reply e24-5. PubMed ID: 21825223
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs for hypertension.
    Med Lett Drugs Ther; 2017 Mar; 59(1516):41-48. PubMed ID: 28263286
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets? Position Statement of the Latin American Society of Hypertension.
    López-Jaramillo P; Coca A; Sánchez R; Zanchetti A;
    Hypertension; 2016 Aug; 68(2):257-62. PubMed ID: 27296997
    [No Abstract]   [Full Text] [Related]  

  • 19. "Treating hypertension" or "lowering blood pressure"? Extending the concept.
    Chalmers J
    Blood Press; 2002; 11(2):68-70. PubMed ID: 12035873
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lowering high blood pressure--to what extent?].
    Meisel S; Rosenthal T
    Harefuah; 1989 Mar; 116(5):290-2. PubMed ID: 2722083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.